miRNA Sequencing and Assay Market Size, Trends, Analysis, and Outlook By Products and Services (Products, Services), By Technology (Sequencing By Synthesis, Sequencing By Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-User (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), by Country, Segment, and Companies, 2024-2032
The global miRNA Sequencing and Assay market size is poised to register 12.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global miRNA Sequencing and Assay market across By Products and Services (Products, Services), By Technology (Sequencing By Synthesis, Sequencing By Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-User (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others)
The future of the miRNA sequencing and assay market is driven by advancements in sequencing technologies, increasing understanding of microRNA (miRNA) biomarkers, and growing applications in disease diagnosis and therapeutic development. miRNAs play a crucial role in gene regulation and have emerged as promising biomarkers for various diseases, including cancer, cardiovascular disorders, and neurological conditions. With the development of next-generation sequencing platforms and bioinformatics tools, researchers can now profile miRNA expression patterns with high throughput and accuracy, enabling the discovery of novel biomarkers and therapeutic targets. Further, the integration of miRNA sequencing with other omics technologies such as genomics and proteomics is driving synergistic approaches for comprehensive molecular profiling. Over the forecast period to 2030, expanding applications in personalized medicine, increasing investments in biomarker discovery research, and rising adoption of miRNA-based diagnostics and therapeutics are expected to drive market growth and innovation.
miRNA Sequencing and Assay Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The miRNA Sequencing and Assay market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of miRNA Sequencing and Assay survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the miRNA Sequencing and Assay industry.
Key market trends defining the global miRNA Sequencing and Assay demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
miRNA Sequencing and Assay Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The miRNA Sequencing and Assay industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support miRNA Sequencing and Assay companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the miRNA Sequencing and Assay industry
Leading miRNA Sequencing and Assay companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 miRNA Sequencing and Assay companies.
miRNA Sequencing and Assay Market Study- Strategic Analysis Review
The miRNA Sequencing and Assay market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The miRNA Sequencing and Assay industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
miRNA Sequencing and Assay Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America miRNA Sequencing and Assay Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various miRNA Sequencing and Assay market segments. Similarly, Strong market demand is encouraging Canadian miRNA Sequencing and Assay companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico miRNA Sequencing and Assay market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe miRNA Sequencing and Assay Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European miRNA Sequencing and Assay industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European miRNA Sequencing and Assay market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific miRNA Sequencing and Assay Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for miRNA Sequencing and Assay in Asia Pacific. In particular, China, India, and South East Asian miRNA Sequencing and Assay markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America miRNA Sequencing and Assay Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa miRNA Sequencing and Assay Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East miRNA Sequencing and Assay market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for miRNA Sequencing and Assay.
miRNA Sequencing and Assay Market Company Profiles
The global miRNA Sequencing and Assay market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abcam plc, HTG Molecular Diagnostics Inc, Illumina Inc, Lexogen GmbH, Maravai LifeSciences, Meridian Bioscience Inc, New England Biolabs Inc, Norgen Biotek Corp, PerkinElmer Inc, QIAGEN N.V., System Biosciences LLC, Takara Bio Inc, Thermo Fisher Scientific Inc.
Recent miRNA Sequencing and Assay Market Developments
The global miRNA Sequencing and Assay market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
miRNA Sequencing and Assay Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products and Services
Products
-Library Preparation Kits
-Sequencing Consumables
-Instruments
Services
By Technology
Sequencing By Synthesis
Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
Nanopore Sequencing
Sanger Sequencing
Single Molecule Real-time (SMRT) Sequencing
By Workflow
Library Preparation
Sequencing
Data Analysis & Storage
By Application
Cancer
Polyglutamine Diseases
Autoimmune Disease
Schizophrenia
Others
By End-User
Pharmaceutical & Biotechnology Industry
Research and Academic Institutes
Others
Geographical Segmentation:
Abcam plc
HTG Molecular Diagnostics Inc
Illumina Inc
Lexogen GmbH
Maravai LifeSciences
Meridian Bioscience Inc
New England Biolabs Inc
Norgen Biotek Corp
PerkinElmer Inc
QIAGEN N.V.
System Biosciences LLC
Takara Bio Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The future of the miRNA sequencing and assay market is driven by advancements in sequencing technologies, increasing understanding of microRNA (miRNA) biomarkers, and growing applications in disease diagnosis and therapeutic development. miRNAs play a crucial role in gene regulation and have emerged as promising biomarkers for various diseases, including cancer, cardiovascular disorders, and neurological conditions. With the development of next-generation sequencing platforms and bioinformatics tools, researchers can now profile miRNA expression patterns with high throughput and accuracy, enabling the discovery of novel biomarkers and therapeutic targets. Further, the integration of miRNA sequencing with other omics technologies such as genomics and proteomics is driving synergistic approaches for comprehensive molecular profiling. Over the forecast period to 2030, expanding applications in personalized medicine, increasing investments in biomarker discovery research, and rising adoption of miRNA-based diagnostics and therapeutics are expected to drive market growth and innovation.
miRNA Sequencing and Assay Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The miRNA Sequencing and Assay market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of miRNA Sequencing and Assay survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the miRNA Sequencing and Assay industry.
Key market trends defining the global miRNA Sequencing and Assay demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
miRNA Sequencing and Assay Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The miRNA Sequencing and Assay industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support miRNA Sequencing and Assay companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the miRNA Sequencing and Assay industry
Leading miRNA Sequencing and Assay companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 miRNA Sequencing and Assay companies.
miRNA Sequencing and Assay Market Study- Strategic Analysis Review
The miRNA Sequencing and Assay market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The miRNA Sequencing and Assay industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
miRNA Sequencing and Assay Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America miRNA Sequencing and Assay Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various miRNA Sequencing and Assay market segments. Similarly, Strong market demand is encouraging Canadian miRNA Sequencing and Assay companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico miRNA Sequencing and Assay market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe miRNA Sequencing and Assay Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European miRNA Sequencing and Assay industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European miRNA Sequencing and Assay market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific miRNA Sequencing and Assay Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for miRNA Sequencing and Assay in Asia Pacific. In particular, China, India, and South East Asian miRNA Sequencing and Assay markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America miRNA Sequencing and Assay Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa miRNA Sequencing and Assay Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East miRNA Sequencing and Assay market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for miRNA Sequencing and Assay.
miRNA Sequencing and Assay Market Company Profiles
The global miRNA Sequencing and Assay market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abcam plc, HTG Molecular Diagnostics Inc, Illumina Inc, Lexogen GmbH, Maravai LifeSciences, Meridian Bioscience Inc, New England Biolabs Inc, Norgen Biotek Corp, PerkinElmer Inc, QIAGEN N.V., System Biosciences LLC, Takara Bio Inc, Thermo Fisher Scientific Inc.
Recent miRNA Sequencing and Assay Market Developments
The global miRNA Sequencing and Assay market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
miRNA Sequencing and Assay Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products and Services
Products
-Library Preparation Kits
-Sequencing Consumables
-Instruments
Services
By Technology
Sequencing By Synthesis
Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
Nanopore Sequencing
Sanger Sequencing
Single Molecule Real-time (SMRT) Sequencing
By Workflow
Library Preparation
Sequencing
Data Analysis & Storage
By Application
Cancer
Polyglutamine Diseases
Autoimmune Disease
Schizophrenia
Others
By End-User
Pharmaceutical & Biotechnology Industry
Research and Academic Institutes
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abcam plc
HTG Molecular Diagnostics Inc
Illumina Inc
Lexogen GmbH
Maravai LifeSciences
Meridian Bioscience Inc
New England Biolabs Inc
Norgen Biotek Corp
PerkinElmer Inc
QIAGEN N.V.
System Biosciences LLC
Takara Bio Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 miRNA Sequencing and Assay Market Overview and Key Findings, 2024
1.2 miRNA Sequencing and Assay Market Size and Growth Outlook, 2021- 2030
1.3 miRNA Sequencing and Assay Market Growth Opportunities to 2030
1.4 Key miRNA Sequencing and Assay Market Trends and Challenges
1.4.1 miRNA Sequencing and Assay Market Drivers and Trends
1.4.2 miRNA Sequencing and Assay Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading miRNA Sequencing and Assay Companies
2. MIRNA SEQUENCING AND ASSAY MARKET SIZE OUTLOOK TO 2030
2.1 miRNA Sequencing and Assay Market Size Outlook, USD Million, 2021- 2030
2.2 miRNA Sequencing and Assay Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. MIRNA SEQUENCING AND ASSAY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. MIRNA SEQUENCING AND ASSAY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Products
-Library Preparation Kits
-Sequencing Consumables
-Instruments
Services
By Technology
Sequencing By Synthesis
Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
Nanopore Sequencing
Sanger Sequencing
Single Molecule Real-time (SMRT) Sequencing
By Workflow
Library Preparation
Sequencing
Data Analysis & Storage
By Application
Cancer
Polyglutamine Diseases
Autoimmune Disease
Schizophrenia
Others
By End-User
Pharmaceutical & Biotechnology Industry
Research and Academic Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific miRNA Sequencing and Assay Market, 2025
5.2 Asia Pacific miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe miRNA Sequencing and Assay Market, 2025
5.5 Europe miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.6 Europe miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America miRNA Sequencing and Assay Market, 2025
5.8 North America miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.9 North America miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America miRNA Sequencing and Assay Market, 2025
5.11 South America Pacific miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.12 South America miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa miRNA Sequencing and Assay Market, 2025
5.14 Middle East Africa miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US miRNA Sequencing and Assay Market Size Outlook and Revenue Growth Forecasts
6.2 US miRNA Sequencing and Assay Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada miRNA Sequencing and Assay Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico miRNA Sequencing and Assay Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany miRNA Sequencing and Assay Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France miRNA Sequencing and Assay Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK miRNA Sequencing and Assay Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain miRNA Sequencing and Assay Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy miRNA Sequencing and Assay Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe miRNA Sequencing and Assay Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China miRNA Sequencing and Assay Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India miRNA Sequencing and Assay Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan miRNA Sequencing and Assay Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea miRNA Sequencing and Assay Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia miRNA Sequencing and Assay Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia miRNA Sequencing and Assay Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific miRNA Sequencing and Assay Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil miRNA Sequencing and Assay Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina miRNA Sequencing and Assay Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America miRNA Sequencing and Assay Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East miRNA Sequencing and Assay Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa miRNA Sequencing and Assay Industry Drivers and Opportunities
7. MIRNA SEQUENCING AND ASSAY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. MIRNA SEQUENCING AND ASSAY COMPANY PROFILES
8.1 Profiles of Leading miRNA Sequencing and Assay Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abcam plc
HTG Molecular Diagnostics Inc
Illumina Inc
Lexogen GmbH
Maravai LifeSciences
Meridian Bioscience Inc
New England Biolabs Inc
Norgen Biotek Corp
PerkinElmer Inc
QIAGEN N.V.
System Biosciences LLC
Takara Bio Inc
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 miRNA Sequencing and Assay Market Overview and Key Findings, 2024
1.2 miRNA Sequencing and Assay Market Size and Growth Outlook, 2021- 2030
1.3 miRNA Sequencing and Assay Market Growth Opportunities to 2030
1.4 Key miRNA Sequencing and Assay Market Trends and Challenges
1.4.1 miRNA Sequencing and Assay Market Drivers and Trends
1.4.2 miRNA Sequencing and Assay Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading miRNA Sequencing and Assay Companies
2. MIRNA SEQUENCING AND ASSAY MARKET SIZE OUTLOOK TO 2030
2.1 miRNA Sequencing and Assay Market Size Outlook, USD Million, 2021- 2030
2.2 miRNA Sequencing and Assay Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. MIRNA SEQUENCING AND ASSAY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. MIRNA SEQUENCING AND ASSAY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Products
-Library Preparation Kits
-Sequencing Consumables
-Instruments
Services
By Technology
Sequencing By Synthesis
Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
Nanopore Sequencing
Sanger Sequencing
Single Molecule Real-time (SMRT) Sequencing
By Workflow
Library Preparation
Sequencing
Data Analysis & Storage
By Application
Cancer
Polyglutamine Diseases
Autoimmune Disease
Schizophrenia
Others
By End-User
Pharmaceutical & Biotechnology Industry
Research and Academic Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific miRNA Sequencing and Assay Market, 2025
5.2 Asia Pacific miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe miRNA Sequencing and Assay Market, 2025
5.5 Europe miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.6 Europe miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America miRNA Sequencing and Assay Market, 2025
5.8 North America miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.9 North America miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America miRNA Sequencing and Assay Market, 2025
5.11 South America Pacific miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.12 South America miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa miRNA Sequencing and Assay Market, 2025
5.14 Middle East Africa miRNA Sequencing and Assay Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa miRNA Sequencing and Assay Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US miRNA Sequencing and Assay Market Size Outlook and Revenue Growth Forecasts
6.2 US miRNA Sequencing and Assay Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada miRNA Sequencing and Assay Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico miRNA Sequencing and Assay Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany miRNA Sequencing and Assay Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France miRNA Sequencing and Assay Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK miRNA Sequencing and Assay Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain miRNA Sequencing and Assay Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy miRNA Sequencing and Assay Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe miRNA Sequencing and Assay Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China miRNA Sequencing and Assay Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India miRNA Sequencing and Assay Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan miRNA Sequencing and Assay Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea miRNA Sequencing and Assay Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia miRNA Sequencing and Assay Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia miRNA Sequencing and Assay Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific miRNA Sequencing and Assay Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil miRNA Sequencing and Assay Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina miRNA Sequencing and Assay Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America miRNA Sequencing and Assay Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East miRNA Sequencing and Assay Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa miRNA Sequencing and Assay Industry Drivers and Opportunities
7. MIRNA SEQUENCING AND ASSAY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. MIRNA SEQUENCING AND ASSAY COMPANY PROFILES
8.1 Profiles of Leading miRNA Sequencing and Assay Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abcam plc
HTG Molecular Diagnostics Inc
Illumina Inc
Lexogen GmbH
Maravai LifeSciences
Meridian Bioscience Inc
New England Biolabs Inc
Norgen Biotek Corp
PerkinElmer Inc
QIAGEN N.V.
System Biosciences LLC
Takara Bio Inc
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
